VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Ception Therapeutics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

Streamlined Payroll Solutions

  • Biotech & therapeutics
Status
Acquiredas of 2026-09-23Source (opens in a new tab)
Business model
B2B
Headquarters
Malvern, Pennsylvania, United States
Claim, correct or request removal

Record updated 28 September 2026

About

Ception Therapeutics was acquired by Cephalon Inc. in March 2010 for $350 million plus significant future millstones with its lead product which was subsequently approved to treat eosinophilic asthma. Industry: Biopharmaceutical | Headquarters: Malvern, Pennsylvania

About the company

Status notes
Ception Therapeutics was acquired by Cephalon Inc. in March 2010 for $350 million plus significant future millstones

Exit

Acquisition
$350M, 2010-03$350 million plus significant future millstones
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy